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Abstract The total cortical and striatal neurone and 
glial numbers were estimated in five cases of Hunting-
ton's disease (three males, two females) and five age-
and sex-matched control cases. Serial 500-l-lm-thick 
gallocyanin-stained frontal sections through the left 
hemisphere were analysed using Cavalieri's principle 
for volume and the optical disector for cell density 
estimations. The average cortical neurone number of 
five controls (mean age 53±13 years, range 36-72 
years) was 5.97x 109±320x 106 , the average number of 
small striatal neurones was 82 X 106± 15.8 X 106 • The left 
striatum (caudatum, putamen, and accumbens) con-
tained a mean of 273 X 106±53 X 106 glial cells (oligo-
dendrocytes, astrocytes and unc1assifiable glial pro-
files). The mean cortical neurone number in Hunting-
ton's disease patients (mean age 49±14 years, range 
36-75 years) was diminished by about 33 % to 
3.99x109±218x106 nerve cells (P ::;:::: 0.012, Mann-
Whitney V-test). The mean number of small striatal 
neurones decreased tremendously to 9.72 X 106 ± 
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3.64 X 106 (-88 % ). The decrease in total glial cells was 
less pronounced (193 X 106±26 X 106) but the mean 
glial index, the numerical ratio of glial cells per neu-
rone, increased from 3.35 to 22.59 in Huntington's dis-
ease. Qualitatively, neuronal loss was most pronounced 
in supragranular layers of primary sensory areas (Brod-
mann's areae 3,1,2; area 17, area 41). Layer HIc pyrami-
dal cells were preferentially lost in association areas of 
the temporal, frontal, and parietal lobes, whereas 
spared layer IV granule cells formed a conspicuous 
band between layer IH and V in these fields. Meth-
odological issues are discussed in context with previous 
investigations and similarities and differences of lami-
nar and lobar nerve cellloss in Huntington's disease are 
compared with nerve cell degent-ration in other neuro-
psychiatric diseases. 
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Introduction 
Huntington's disease, a hereditary, autosomal dominant 
neurodegenerative disorder, is clinically characterized 
by the triad of motor disturbances, cognitive defects, 
and emotional disturbances [39]. Neuropathologically, 
Huntington's disease is diagnosed by bilateral degener-
ative changes in the striatum [31, 119] and nerve cell loss 
in this complex and functionally related structures [28, 
74, 75, 79]. Vonsattel et al. [120] proposed a simple pro-
cedure for the neuropathological grading of caudate 
atrophy. Myers et al. [86] correlated macroscopical 
grading of striatal atrophy and reduced nerve cell num-
ber with physical disability rating in a large sample of 
patients. The neurological signs are explained by nerve 
cell loss in the striate body. Choreic movements in early 
stages of Huntington's disease are believed to result 
from inhibition of the subthalamic nucleus [2] by selec-
tive degeneration of enkephalin-positive projection 
neurones directed to the globus pallidus externus [96], 
oculomotor disturbances from an interruption in the 
oculomotor-basal ganglia-thalamocortical circuit [3, 4], 
rigidity and bradykinesia from GABA imbalance in the 
globus pallidus externus/internus transmitter ratio 
[114]. On the other hand, early stages of Huntington's 
disease are frequently diagnosed as major depressive 
diseases, schizophrenia, or personality disorders in psy-
chiatric institutions [39]. Psychiatric signs are known to 
precede movement disorders by years. The former clin-
ical pictures are less well explained by neuronal degen-
eration in the striate body. It is argued that atrophy in 
the striate body disrupts the neuronal loop between 
prefrontal cortical regions and thalamic feedback [3, 4, 
71, 85, 98, 115]. Other investigators explain cognitive 
deficits by global cortical, subcortical, and white matter 
atrophy [28, 79], selective laminar loss of a non-
phosphorylated neurofilament (SMI-32 ir) bearing 
pyramidal cells [25], and reduced nerve cell density in 
layers V and VI of the prefrontal cortex [108, 109]. In 
these investigations, nerve cell density estimations were 
thought to reflect total neuronal loss. This assumption 
has been shown to be problematic in ageing research 
[15, 30, 38, 70] as well as in the calculation of total 
astroglial number in Huntington's chorea [74] since 
complex agonal, post mortem, and technical factors are 
known to influence nerve cell density in an unpredict-
able manner. These factors cannot be compensated by 
strict protocols of fixation, embedding, and staining 
procedures. Therefore, our study is intended to supple-
ment previous quantitative investigations by an 
unbiased estimation of total hemispheric nerve cell 
number using Cavalieri's principle for volume and the 
optical disector for nerve cell density estimation [16, 45, 
91, 95, 122, 123]. 
Materials and methods 
Five brains of patients with the clinical diagnosis of Huntington's 
disease (two females, three males) and five age- and sex-matched 
control brains without a history of neurological or psychiatric dis-
eases were fixed in 4 % formalin (one part of commercial 37 % 
formaldehyde added to nine parts of tap water) for at least 3 
months [9, 113]. After removal of the meninges the brain stem and 
cerebellum were severed at the level of the rostral pons. The plane 
of section was perpendicular to the longitudinal axis of the brain 
stem. Both hemispheres were subdivided by a mediosagittal cut 
and the left hemispheres were pre-treated in ascending concentra-
tions of glycerol-DMSO-formalin mixtures, embedded in gelatine, 
and soaked again in glycerol-DMSO-formalin mixtures. After 
these cryoprotective procedures [102], the embedded hemispheres 
were deep-frozen in -60°C isopentane and serially sectioned on a 
Tetrander (Jung, Nussloch) at 600-700 !-lm thickness. Section 
thickness cannot be directly read from the microtome. It must be 
optically determined in unstained as well as stained sections (for 
details see [58]). Due to staining, dehydration, and mounting pro-
cedures section thickness linearly decreases by about 20% to 
480-540 !-lm. The slices were alternatingly collected in three 
plastic boxes and stored in 4 % formalin. For routine and quanti-
tative examinations each third section from the fronto-parallel 
series was Nissl stained with gallocyanin. Details of the staining 
and mounting procedures are given elsewhere [10, 54]. Small tis-
sue samples (maxim ally 30x 15 mm) of the first frontal gyrus 
(Brodmann's area 8), of the head of the caudate nucleus rostral to 
the anterior commissure, and of the ventral striatum at the level of 
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entrance of the anterior perforating arteries were dissected from 
the parallel formalin-fixed but unstained serial sections. These tis-
sue segments were dehydrated, paraffin embedded and stained 
with van Gieson stain [101] and Gallyas' silver impregnation for 
the demonstration of fibrous astroglia [41]. Slides were coded and 
diagnosed without knowledge of the clinical history. 
An additional unstained thick frozen section was taken at the 
level of the rostrallateral geniculate body and stained by a modi-
fied Gallyas technique [55] to exclude senile changes. 
The quantitative composition of serial gallocyanin-stained and 
parallel unstained sections was determined by point counting 
methods. For this a transparent square lattice test system [121], 
consisting of coarse test lines spaced at 12 mm, was laid upon the 
unstained and parallel stained sections. Each square of coarse test 
lines was subdivided by 16 finer test lines spaced at 3 mm. The 
coarse and fine crossing lines formed the centre points. The num-
ber of coarse centre points or hits that fall on to either cortex or 
white matter yield a simple estimation of the quantitative com-
position of the cerebral hemispheres. The number of hits of points 
(Pp) multiplied by the area of the coarse squares (d2= 12 x 12 
mm=144 mm2), the section thickness, and the factor k yield the 
volumes of cortex and white matter of unstained and gallocyanin 
stained cerebral hemispheres. The factor k indicates the spacing of 
serial sections. It was three in our investigation since we used 
every third section for the quantitative analysis. 
The volume of stained hemispheres divided by the volume of 
unstained hemispheres yields the shrinkage factor (Sf). Nerve cell 
density of stained sections multiplied by the shrinkage factor 
yields the nerve cell density of the fresh volume (or in vivo nerve 
cell density) assuming reversal of initial swelling of the nervous 
system after prolonged (at least 3 months) formalin fixation [9, 
113]. 
The volumes of subcortical structures including striatum, 
claustrum, nuclear complex of thalamus, and amygdaloid bodies 
were likewise estimated. The number of hits of crossing points of 
the fine lines was used for analysis of the subcortical nuclear vol-
ume. Note that d2 in this case is 3x3=9 mm2 • 
To obtain the total cell number within a reference volume (cor-
tex or subcortical nuclei), the average nerve cell density must be 
multiplied by the volume of the cortex or subcortical nuclei. 
Braendgaard et al. [16] proposed a simple procedure to obtain an 
unbiased estimation of nerve cell density in the human cerebral 
cortex. In analogy with Braendgaard et al. [16] each fourth 
gallocyanin-stained section was centred onto a circle. This circle 
was subdivided by 30 beams (numerated clockwise from 0-29) 
radiating at angles of 12° from the centre of the circle. A random 
number between 0 and 29 was generated by a computer program 
and the course of the beam, e.g. 5, running through the cortex was 
marked by ink on the microscope slide. The ensuing section was 
likewise centred onto the circle and the course of the next beam, 
in this case 6, penetrating the cortex was traced by ink on this 
microscope section. The procedure was repeated going clockwise 
from 5 to 29 or, in larger brains, continuing the cycle from 0 pass-
ing all beams of the circle. Thus, a helical, systematically random 
probing of nerve cell density is achieved. Neo-, periarchi-, and 
archicortical regions were analysed without further subdivision. 
The cortical nerve cell density was determined at higher mag-
nification. A combination of a high power (Planapo oil immersion 
40/1.0) objective and a 5x5 mm ocular grid subdivided by lOxlO 
lines inserted into a widefield (lOx) eyepiece were used. A ran-
dom number 1, 2 or 3 was generated by a computer program. If 
random number 1 was selected, we started nerve cell density 
determinations in the molecular layer. Going strictly parallel to 
the ink line painted onto the microscope slide the visual field was 
moved 0.375 mm into the cortex and the nerve cell number was 
counted again. This procedure was repeated until the visual field 
fell outside the cortical boundaries. If random number 2 
appeared, the visual field was moved 0.125 mm below the pial sur-
face and nerve cell number counting was started in layer 11. The 
visual fields were then moved by 0.375-mm intervals through the 
cortex until the visual field fell into the medullary layer. For ran-
dom number 3, the visual field was shifted by 0.25 mm into the 
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cortex (or upper layer Ill) prior to nerve cell density counting. 
Nerve cell density of the adjoining deeper parts of the cortical rib-
bon were counted at 0.375-mm intervals identical to the proce-
dures described above. Depending on the random number, the 
starting points of nerve cell density counting were systematically 
permutated from 1, 2, 3, 1,2,3 ... ,3, 1,2,3, 1,2 ... or 2,3, 1,2, 
3, 1 ... following individual beams penetrating the cortex. These 
procedures guarantee a homogeneous unbiased estimation of 
nerve cell densities. At variance with Braendgaard et al. [16] who 
had to re-embed, cut, and stain wedges from their 7-mm cortical 
slabs, we could record nerve cell density directly from our 0.48- to 
0.54-mm-thick gallocyanin-stained sections without further his-
tological processing. 
Nerve cell density was obtained with the optical disector. This 
method allows an unbiased estimation of cell densities [16, 45, 91, 
95,122,123]. We counted all neuronal nucleoli oflarge nerve cells 
or all neuronal nuclear profiles of small nerve cells (Qi), respec-
tively, that came anew into the visual field (F) after focusing on 
superficial parts of the sections. For this purpose, the fine adjust-
ment knob of the microscope was mechanically stopped after opti-
cally penetrating the section for 29.7. [.lm. An average of 250 opti-
cal fields with an average of 700 neuronal profiles per case were 
counted. The quotient QJFi yields the average nerve cell density. 
Granule cells were distinguished from cortical astrocytes by 
their oval nucleus and the presence of a small basophilic cyto-
plasm. Nevertheless, it was not always possible to decide whether 
a nuclear profile belonged to a reactive astrocyte, to a small layer 
II or layer IV granule cell, or to an otherwise unspecified interneu-
rone. These nuclear profiles were recorded as unidentified cell 
types. 
Nerve cell density in the striatum was counted by a slightly dif-
ferent procedure. Pairs of random numbers 1-4 or 0-3 were gen-
erated by a computer program. These random numbers were 
associated with the axes of an imaginative Cartesian system, the y-
axes (random number 0-3) of which ran parallel to the ventricular 
surface of the caudate nucleus. The x-axes (random number 1-4) 
pointed in medio-lateral direction (Fig. 1). If random number 
pairs 0/1 were selected, nerve cell density was counted in the dor-
some dial part of the caudate nucleus. After this, the mechanical 
stage of the microscope was parallelly moved 2 mm on the x-axis. 
If the visual field was within the boundaries of the caudate 
nucleus, nerve cell density was again determined, if not, the 
mechanical stage was moved an additional 2 mm in lateral direc-
tion until the visual field hit either striatal cell bridges or neurones 
of the dorsomedial putamen. In the absence of the putamen, the 
mechanical stage was moved 2 mm ventrally and then 2 mm medi-
ally until the microscope field fell within the caudate boundaries. 
These mediolateral and dorsoventral 2-mm steps provide a 
Table 1 Summary of clinical data and neurological signs 
Age Sex Family Anamnesis 
(years) history 
Fig. 1 Striatum of a 46-year-old female control case (Acc nucleus ~ 
accumbens; vP ventral putamen) 
Fig.2 Striatum of a 41-year-old female Huntington's patient. Pal-
lor of caudate nucleus and putamen. Conspicuous and typical 
about 0.5-mm-wide subventricular strip (arrows) which is com-
pletely devoid of neurones. Numerous tenuous fibre bundles are 
piercing both striatal nuclei. At variance with the normal controls, 
these fibre bundles contain an abundance of intensely basophilic 
oligodendrocytes that render these bundles visible at low-power 
magnification. Cell density in the nucleus accumbens (Acc) is less 
reduced than in the dorsal parts of the striatum. Bar=l mm 
systematic random probing of visual fields within the striatal 
components of one section. In the subsequent section, the co-
ordinates of the starting point were enhanced by one (1/2 instead 
of 0/1) and neurone density was counted similar to the procedure 
described above. These steps were repeated until random number 
pairs 0/4 were achieved after four consecutive sections. In the 
fourth section, the sampling cycle was started again at the dorso-
medial parts of the caudate nucleus. This sampling scheme provi-
des an unbiased cell density estimation throughout the striatum. 
Nucleoli of small striatal neurones were counted with the opti-
cal disector described above using the same objective/eyepiece 
combination. Nuclear profiles of astrocytes were recognized by 
their fine, evenly distributed heterochromatin granules. Nuclear 
profiles of oligodendrocytes were smaller than astrocytic profiles, 
frequently clustered either within fibre fascicles or encountered as 
perineuronal satellites. Nevertheless, a precise classification of 
glial cells was impossible in gallocyanin stained sections. Equivo-
cal profiles were assigned unidentified cells in Table 4. 
The precision (see CENi , Table 4) of the quantitative procedure 
can be calculated from Pi, Qi and Fi of the individual serial sec-
tions [124]. Selected data were subjected to Mann-Whitney U-
tests at the "Rechenzentrum der Universitat Wiirzburg". 
Results 
Clinical data and course of the disease 
The clinical data as well as onset and duration of overt 
neurological signs are summarized in Table 1. Notably, 
only one of the patients (male, aged 40 years) exhibited 
neurological signs from the beginning of the disease 
Age of onset/ 
duration of 
neurological signs 
36 Female Yes Elementary school with good results; apprenticeship not completed; several 24 years/12 years 
jobs; married; 1983 diagnosis schizophrenia-like psychosis associated with 
probable Chorea Huntington 
40 Male Yes Elementary school; completed apprenticeship; predominantly neurological 29 years/ll years 
signs, inability to perform manual skills and to continue his job; suicidal 
behaviour at the age of 35 
41 Male Yes Elementary school; completed 3-year-apprenticeship at the German Federal 29 years/12 years 
Post Offices and occupation at this institution for 2 years; thereafter various 
jobs, alcoholism, promiscuity; confined for fraud and theft to several years.of 
imprisonment; confined to State Psychiatric Hospital at the age of 36; mamc-
depressive episodes, nocturnal agression, progressive dementia 
54 Female Yes Housewife; married; at the age of 30 change of personality, aggressive and 36 years (?)/ 
paranoid behaviour 18 years 
72 Male Possible Tram driver; had to resign from his occupation by neglect of red traffic signal 65 years/7 years 
at the age of 54; disturbance of concentration and memory, aggression, 
paranoid ideation 
~I 
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Fig. 3 Pre- (area 4; area FAgamma of Economo and Koskinas 
[33]) and postcentral gyrus (area 3, 1, 2; areas PB, PC, PD of Eco-
nomo and Koskinas) of a 36-year-old male control case. The post-
central region is characterized by a thin, heterotypical cortex, high 
cell density in the supragranular layers (white star) , a small and 
pale layer V (thin arrows) , and a thin , cell-rich and well-
demarcated layer VI (thick arrows). The cortex of area 4 is slightly 
obliquely cut , individual Betz cells (B with arrows, and thin arrow, 
upper right margin) can be recognized at this magnification. 
Bar= l mm 
that forced him to resign from his job. Memory distur-
bances were noticed in the oldest of our cases, whereas 
the symptoms of the 36-year-old female had originally 
been diagnosed as schizophrenic. 
Routine neuropathology 
Arteriosclerotic changes were absent from larger pene-
trating and subcortical arteries in the control and Hunt-
ington's disease cases. Some penetrating arteries within 
the ventral putamen and the rostral globus pallidus 
externus exhibited increased basophilia of their muscu-
lar layer in gallocyanin-stained sections. These pheno-
Fig. 4 Pre- (area 4; area FAgamma [33]) and postcentral gyrus 
(area 3, 1, 2; areas PB , PC, PD [33]) of a 40-year-old male Hunt-
ington's patient. Pallor of the supragranular layers in the postcent-
ral gyrus (white star) , attenuation of layer VI (thick arrow) , con-
spicuous layer IV (thin arrows). The width of area 4 appears not to 
be reduced , Betz cells are not visible by technical reasons due to 
their reduced basophilia but their density is unchanged . Same 
scale as Fig. 3 
mena were observed in both Huntington's disease and 
control cases. Excessive fibrosis of cerebral arterioles 
was not encountered either in the 72-year-old male 
Huntington's or in the 75-year-old control case. Alzhei-
mer's neurofibrillary tangles, senile or amyloid plaques 
were not present either in the controls or in the cases 
with Huntington's disease. The coded sections through 
the basal ganglia from Huntington's disease could be 
unequivocally diagnosed by a marked increase of fi-
brous astrocytes in Gallyas-stained sections and by a 
considerably decreased density of small striatal neuro-
nes (Figs. 1, 2). 
Fig. 5 Inferior temporal gyrus covered by Brodmann's area 20 
(TE2 in [33]) of a 36-year-old male control case. This field is classi-
fied frontal type 2 by its lamination [33). The cortex is wide and 
pyramidal cells predominate , especially in layer V (thick arrows). 
Although Economo and Koskinas [33] did not mention a well-
developed layer IlIe in their monograph , isolated large IlIe pyra-
midal neurones are described in the English translation [32] . 
These cells form a clear-cut row in thick gallocyanin-stained sec-
tions (thin arrows) separated by a cell-poor cleft from layer IV. 
Bar=l mm 
Laminar pathology in thick frozen gallocyanin-stained 
sections 
Cytoarchitectonically, primary sensory fields are cha-
racterized by thin, cell-rich cortical ribbons. The term 
koniocortex is used to express granularisation of neu-
rones in layers Il to IV. Layer Vb is cell sparse and layer 
VI thin and well demarcated (Fig. 3). These primary 
sensory fields comprising Brodmann's areae 3, 1, 2, 41, 
Fig. 6 Inferior temporal gyrus covered by Brodmann's area 20 
(TE2 in [33]) of a 40-year-old male patient with Huntington's dis-
ease. The overall width of area 20 is higher in the Huntington's 
patient. The brain of the control case (Fig. 5) was subdivided by 
numerous tertiary gyri. In our experience , heavy brains are fre-
quently well gyrated and are covered by a thin expanded cortex, 
whereas in less-well gyrated brains the cortices are thicker. Fur-
thermore , the cortical shrinkage factor was 0.53 in the control case 
and 0.49 in the patient with Huntington's disease (Table 2). These 
fundamental differences in gross anatomy in association with tech-
nical factors render assessment of cortical thickness difficult. The 
row of layer HIc pyramidal cells is absent and layer IV together 
with superficial layer V pyramidal cells (thin arrows) is prominent 
in temporal association fields of Huntington's disease patients . 
Both corrected cortical volumes were nearly identical (Table 2) 
and 17 were heavily afflicted by conspicuous nerve cell 
loss in layers III and VI (Fig. 4) . Only few, unusually 
large pyramidal cells were spared in layer III of the pri-
mary sensory fields. Neurones in layers IV and Va 
appeared resistant to cell degeneration and these layers 
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Table 2 Summary of cortical and subcortical volumes and Sf values (Sf shrinkage factor, HD Huntington's disease, Contr. control, n.d. 
not determined. Due to rounding errors the quotients of stained and unstained volumes (Sf) may differ from values in Table 2.) 
Diagnosis Age Volume of Volume of Sf Volume of Volume of Sf Volume of Volume of Sf 
and sex (years) unstained stained left cortex unstained stained white unstained stained striatum 
left cortex cortex medulla medulla matter striatum striatum 
(cm3) (cm3) (cm3) 
HD female 36 160 93 0.58 132 
HD male 40 262 127 0.49 227 
HD male 41 160 103 0.64 122 
HD female 54 212 108 0.51 148 
HD male 72 215 108 0.50 148 
Mean 49 202 108 0.54 155 
SD 15 43 12 0.07 42 
Contr. male 36 265 141 0.53 253 
Contr. female 46 202 135 0.67 229 
Contr. male 49 281 150 0.53 304 
Contr. female 58 236 129 0.55 212 
Contr. male 75 n.d. 133 n.d. n.d. 
Mean 53 246 138 0.57 249 
SD 13 35 8 0.07 40 
Sf = shrinkage factor, n.d. = not determined 
formed a basophilic cell band separating the pale supra-
and infragranular layers. 
In the human neocortex, primary sensory fields are 
surrounded by an excess of associational fields. At low 
power microscope investigation, the neocortical ribbon 
of associational fields appeared remarkably well pre-
served in Huntington's disease cases. The border 
between lamina IV and superficial lamina V was more 
pronounced in most fields of the cortical lobes of cases 
with Huntington's disease than in matched controls. 
The overall cortical thickness was reduced in all cases 
with Huntington's disease, and the supragranular layer 
was less chromophilic due to a slight to intermediate 
(cm3) (cm3) (cm3) 
90 0.68 4.13 1.71 0.41 
170 0.75 3.91 2.41 0.62 
108 0.88 3.30 2.16 0.66 
135 0.91 3.59 2.28 0.63 
98 0.66 4.64 2.87 0.62 
120 0.78 3.91 2.29 0.59 
32 0.11 0.52 0.42 0.10 
192 0.76 8.90 4.99 0.56 
138 0.60 8.22 4.68 0.57 
241 0.79 7.00 5.50 0.79 
164 0.77 7.51 4.88 0.65 
n.d. n.d. n.d. 4.63 n.d. 
184 0.73 7.91 4.94 0.64 
44 0.09 0.83 0.35 0.10 
loss of neurones. An increase of astroglial cells, which 
blurs in our experience the laminar boundaries in a 
highly characteristic manner, was not noted. After care-
ful examination of the temporal (Brodmann's [18] areas 
20 and 21; von Economo and Koskinas' [33] fields TE2 
and TE1) and parietal (Brodmann's areas 7,40, and 39; 
von Economo and Koskinas' fields PE, PF, and PG) 
neocortex a nearly complete absence of layer HIc pyra-
mids was noted (Figs. 5, 6). The assessment of HIe neu-
ronal depletion was difficult to accomplish due to the 
irregular convolution of the respective hemispheric 
gyri, interareal differences and probable interindividual 
differences. In most cortical fields, a few, widely 
Table 3 Summary of corrected cell densities (cm-3) and glial index. Cortical and small striatal neurone density multiplied by volumes 
of stained cortex and striatum, respectively (Table 2), yields total neurone numbers in cortex and striatum. Due to rounding errors these 
products differ from data given in Table 3 (n.d. not determined). 
Diagnosis Age Cortical Corrercted Density of Corrected Density of Corrected Glial index: 
(years) neurone cortical small striatal density of striatal glial density of glial cells/ 
density neurone neurones small striatal & uniden- striatal glial small striatal 
density neurones tified cells & uniden- neurone 
tified cells 
HD female 36 42,022 24,371 5,811,651 2,406,527 94,634,475 39,186,874 16,28 
HD male 40 33,075 16,048 2,648,709 1,633,863 90,494,127 55,821,534 34,17 
HD male 41 35,963 23,094 2,526,413 1,655,369 78,247,668 51,269,821 30.97 
HD female 54 38, 543 19,604 5,647,277 3,583,694 93,782,571 59,513,289 16.61 
HD male 72 36,135 18,179 4,755,602 2,938,684 71,083,056 43,925,166 14.95 
Mean 49 37,147 20,259 4,277,930 2,443,627 85,648,379 49,943,337 22.59 
standard 15 3,344 3,444 1,595,130 840,131 10,456,044 8,363,860 9.20 
deviation 
Contr. male 36 41,722 22,175 15,119,751 8,478,285 61,617,845 34,551,736 4.08 
Contr. female 46 43,997 29,449 15,817,086 9,004,032 59,585,126 33,919,422 3.77 
Contr. male 49 39,780 21,238 17,378,082 13,663,059 51,987,794 40,874,034 2.99 
Contr. female 58 42,708 23,313 20,769,949 13,490,478 63,449,035 41,211,357 3.05 
Contr. male 75 48,291 n.d. 13,619,340 n.d. 39,177,088 n.d. 2.88 
Mean 53 43,300 24,044 16,540,842 11,158,964 55,163,378 37,639,137 3.35 
SD 13 3,187 3,702 2,723,271 2,800,965 9,943,716 3,940,966 0.53 
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spaced, unusually large layer III pyramidal cells could Total nerve cell number in Huntington's disease 
be observed at the layer Ill/IV border at higher micro-
scope magnification. Reduced cortical neurone number 
in H untington's disease 
Volumes of cortex, subcortical nuclei 
and white matter, uncorrected 
and corrected cell densities and glial index 
The mean volume of the stained left cortex in Hunting-
ton's disease was by 26.7% lower than the correspond-
ing cortical ribbon in the five control case (Table 2, P ::::; 
0.012). Point counting in gallocyanin-stained serial sec-
tions of cerebral hemispheres and point counting in 
parallel, formalin-fixed unstained sections provide data 
on tissue shrinkage of our frozen sections during his-
tological procedures. The shrinkage factor Sfcortex repre-
sents the volume ratios of the stained cerebral cortex 
divided by the volume of the unstained cortex (Table 
2). Likewise, the volume ratios of stained and unstained 
white matter as well as stained and unstained subcor-
tical nuclei yield shrinkage factors of the white matter 
and subcortical nuclei including striatum, thalamus, 
globus pallidus, and amygdala, respectively (Table 2, 
Sfwhittematten Sfstriatum)' The shrinkage factors of white mat-
ter differed considerably from that of the cortex, the 
means of the cortical and striatal shrinkage factors dif-
fered by less than 10 % , but individual shrinkage factors 
may also diverge considerably. Multiplication of neu-
rone densities by shrinkage factors of the containing 
space (cortex, striatum) yields corrected cell densities 
(Table 3). The glial index is the quotient from striatal 
glial densities and striatal neurone densities (Table 3). 
It was 3.35 in controls and nearly seven times higher in 
Huntington's disease (Table 3). 
The mean total nerve cell number in the left cerebral 
cortex of Huntington's disease patients was 
3.99x109±218x106 neurones (Table 4). This number 
represents a mean 33 % deficit compared with the age-
and sex-matched controls, where the left cerebral cor-
tex contained an average of 5.97x109 ±321x106 neu-
rones. The total nerve cell number in control cases was 
invariably higher than in cases with Huntington's dis-
ease patients (Mann-Whitney V-Test, P::::; 0.012). 
The distinction between small granule and astroglial 
cells was not always possible in gallocyanin-stained sec-
tion. Equivocal nuclear profiles were recorded as un-
identified cortical cells. Their average number was 
573 x 106± 123 x 106 in controls and 605 x 106±95 x 106 in 
Huntington patients (Table 4). These means did not dif-
fer significantly (Mann-Whitney V-test P ::::; 0.53). 
Decreased striatal nerve cell number 
The conspicuous striatal atrophy was associated with a 
tremendous decrease of small striatal neurones. The 
average number of small striatal neurones in controls 
was 82x106±15.8x106 versus 9.72x106±3.64x106 in 
Huntington's disease cases. An enormous individual 
variability could be observed. A maximal number of 
13.65x 106 striatal cells was found in a 72-year-old Hunt-
ington patient and a minimal number of 5.46x106 stria-
tal neurones in 41-year-old male with Huntington's dis-
ease (Mann-Whitney V-test P ::::; 0.012). 
Table 4 Summary of total cell numbers CENE precision of quantitative procedure: see Materials and methods) 
Diagnosis Age Number Number CE Number CD Number Number Number Total number 
(years) of cortical of unidenti- Necort of small Nestriat of astrocytes of oligo- of unidenti- of striatal 
neurones fied cortical striatal dendro- fied cells glial & 
cells neurones cytes unidenti-
fied cells 
HD female 36 3,910,567,297 410,773,875 0.10 9,929,347 0.10 33,688,466 117,909,630 10,226,856 161,824,952 
HD male 40 4,222,175,066 668,859,416 0.11 6,664,042 0.11 69,489,730 119,736,151 28,864,965 218,090,846 
HD male 41 3,705,315,573 541,546,122 0.12 5,461,793 0.12 37,316,853 124,475,493 7,222,617 169,014,963 
HD female 54 4,198,785,877 524,848,234 0.09 12,890,954 0.09 35,477,568 157,251,923 21,094,770 213,824,261 
HD male 72 3,914,247,367 720,718,562 0.07 13,651,218 0.08 51,274,831 133,096,370 19,637,169 204,008,370 
Mean 49 3,990,218,236 573,349,242 0.10 9,719,471 0.10 45,449,490 130,493,913 17,409,275 193,352,678 
standard 15 218,282,961 123,120,313 0.02 3,640,895 0.02 15,130,833 16,070,772 8,734,048 26,129,142 
deviation 
Contr. male 36 5,917,773,275 585,918,146 0.06 75,390,026 0.06 34,914,522 261,295,775 11,262,749 307,473,046 
Contr. 46 5,959,412,636 595,941,263 0.04 74,022,643 0.04 50,814,224 201,953,965 26,090,202 278,858,391 
female 49 5,996,161,154 530,372,976 0.06 95,546,875 0.06 48,127,315 219,403,934 18,401,620 285,932,869 
Contr. male 58 5,548,272,552 544,208,551 0.07 101,333,877 0.07 95,704,217 184,371,359 29,555,714 309,631,290 
Contr. 75 6,449,708,664 767,109,561 0.06 63,803,792 0.06 73,098,665 95,784,458 12,591,231 181,474,354 
female 
Contr. male 
Mean 53 5,974,265,656 604,710,099 0.06 82,019,442 0.06 60,531,789 192,561,898 19,580,303 272,673,990 
standard 13 320,705,314 94,855,232 0.01 15,777,727 0.01 23,976,929 61,167,821 8,082,477 52,697,805 
deviation 
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Correlation of total cortical 
with total striatal neurone number 
In our control sample of five cases, striatal neuronal 
number (Y) correlated negatively with the total cortical 
neurone number (X). This statistically non-significant 
correlation was expressed by the equation 
Y = -3.9131124xlO-2 xX+315.79x106 
with Spearman' rank correlation coefficient 12 = -0.700, 
P:::::: 0.19. 
In the five cases with Huntington's disease, striatal 
number (X) correlated positively with total cortical 
neurone number (Y), although statistically less signifi-
cant (12 = 0.300, P :::::: 0.62) by the equation 
Y = 4.4616754 x IO-3xX-8.083x 106 • 
Neuroglia 
The mean number of astrocytes, oligodendrocytes, and 
unidentified glial cells was higher in the control cases 
(Table 4). In Huntington's disease, the majority of 
astroglial nuclei were considerably enlarged and the 
astroglial perikaryon contained numerous fine lipofus-
cin granules. Astroglial cells could well be distinguished 
from oligodendrocytes in Huntington's disease, whereas 
in the controls the distinction was based mainly on size 
differences and remained arbitrary. 
Discussion 
Methodological considerations 
Our quantitative results of reduced cortical nerve cell 
number in Huntington's disease patients substantiate 
qualitative observations [5, 19, 20, 40, 46, 80, 83, 99, 
116] and extend previous quantitative investigations on 
cortical atrophy [28, 74, 75, 79] and reduced nerve cell 
density [25, 53,108, 110]. 
The overall 33 % decrease in total neurone number 
results from a combined decrease of cortical volume 
and decreased neurone density (Tables 2 and 3). Cor-
tex, subcortical nuclei, and white matter of individual 
brains are prone to considerably divergent shrinkage 
factors (Table 2). Therefore, neurone or glial densities 
(or reconstruction of cell size) must always be corrected 
with individual as well as tissue-specific shrinkage fac-
tors to obtain fresh volumes that reproduce cell den-
sities or cell sizes in unfixed (in vivo) tissue [69]. By cal-
culating total cell number these factors are eliminated. 
To our knowledge, the present data together with a pre-
liminary report [56] are the first estimations of total 
neuronal cortical number in Huntington's disease pa-
tients. Total nerve cell number in both hemispheres was 
estimated to range from lOx109-15x109 neurones 
[49-51]. These results are in agreement with our estima-
tions of an average of 5.97x109 neurones in one hemi-
sphere but our and Haug's data are only half the num-
ber given by other authors [16, 89-91]. This is difficult 
to explain since our stereological procedures were 
nearly identical to those applied by Braendgaard et al. 
[16]. One explanation could be the classification of cel-
lular profiles in gallocyanin-stained preparations. 
Sometimes, we found it difficult to distinguish astroglial 
nuclei from small neocortical layer 11 and layer IV gran-
ule cells. Equivocal profiles were quantified as un-
identified cell types in Table 4. This uncertainty was the 
main reason for abandoning glial counting in the cere-
bral cortex. Braendgaard et al. [16] used the Giemsa 
stain in their investigation. This mixture could probably 
stain perikarya that were only weakly or not at all 
stained by gallocyanin. At variance with our protocol, 
Braendgaard et al. [16] estimated the volume of the 
human prosencephalon in unstained 5-mm-thick frozen 
sections. The nerve cell density was estimated after 
embedding small cortical wedges in glycol methacry-
late. Braendgaard et al. [16] observed up to 15 % tissue 
shrinkage after glycol methacrylate embedding, but 
they did not correct the nerve cell density estimations. 
Finally, Braendgaard et al. [16] removed the medullary 
layer prior to glycol methacrylate processing. Layer VIb 
is known to have uncertain boundaries with the under-
lying medullary layer outside primary sensory fields. 
Exclusion of deep layer VI with its very low neuronal 
density could introduce a bias in average nerve cell den-
sity estimations and result in overestimation of total 
nerve cell number. On the other hand, our uncorrected 
nerve cell densities (Table 3) are nearly identical to 
those of Braendgaard et al. [16]. 
According to Schroder et al. [107] the total number 
of small striatal neurones is 110 X 106 in males and 
105 x 106 in females. These data were derived from a 
total of 13 individuals, 9 males and 4 females, ranging in 
age from 19 to 99 years. In a subsequent study, Lange et 
al. [74] reported 97.8x106 microneurones in the stria-
tum of 6 males and 98.7x106 neurones in the striatum 
of 8 females. In 5 cases of Huntington's disease, Lange 
et al. [74] observed a 92.4 % decrease of microneurones 
to an average of 7.42 X 106 • The total number of small 
striatal cells in these previous investigations is about 
20 % higher than in our control cases and 24 % less than 
in our Huntington's diseases subjects. This difference is 
most likely due to different approaches in counting and 
sampling as well as individual differences in striatal 
neurone number (see also Table 3). Schroder et al. [107] 
recorded the nucleolar number of small striatal neu-
rones at 375-fold microscopic magnification. In our 
experience, even using an oil-immersion objective, 
heterochromatin granules can be confused with nucleo-
lar profiles. In addition, nerve cell density was exclu-
sively estimated by Schroder et al. [107] in intermediate 
parts of the putamen, whereas we were meandering 
through all parts of the striatum, the caudate nucleus as 
well as the ventral striatum and nucleus accumbens 
(Fig. 1). 
Lange [75] calculated a total striatal glia number of 
422.5x106 cells in six females and eight males. This 
mean number is considerably higher than our estima-
tion (272.7 X 106 cells, including unidentified cells, Table 
4). The same holds true for total glia number in Hunt-
ington's disease. We found 193 x 106 glial together with 
unidentified cells in the striatum of Huntington's dis-
ease patients (Table 4), Lange [75] reported 363x1()6 
glial cells in five Huntington patients. Lange [75] did 
not mention correction procedures that have a great 
impact on nuclear instead of nucleolar profile counting 
in 20-!lm-thick paraffin sections. Nevertheless, our data 
confirm the observation of Lange et al. [74] of a 
reduced total astroglia number in Huntington's disease 
despite the drastically increased glial density in the 
visual field. The glial index, the ratio of glial cells per 
neurone, is nearly identical to the number reported by 
Schroder et al. [107]. This ratio increased markedly to 
22.6 glial cells per neurone in Huntington's disease 
(Table 3). 
Laminar and areal versus diffuse nerve cell loss 
The total nerve cell number was investigated in five ter-
minal cases of Huntington's disease. The average deficit 
in neurone number of 33 % observed in our Hunting-
ton's disease patients (Table 4) is a consequence of a 
long-lasting process afflicting cortical as well as subcor-
tical structures. Nevertheless, neuronal degeneration 
was not uniformly distributed over the cerebral cortex 
and its laminae. Primary sensory areas including Brod-
mann's areae 3, 1, 2 (Fig. 4), area 17, and area 41 exhib-
ited a conspicuous neuronal depletion of the supragran-
ular layers. This contrasts with subtle changes in the 
temporal association fields comprising areas 20,21 (Fig. 
6), and parietal association fields. In our preparations, 
these fields were characterized by the nearly complete 
disappearance of HIc pyramidal neurones with a few 
widely dispersed large pyramidal cells spared. Neuronal 
loss in prefrontal and premotor fields appeared inter-
mediate between primary sensory and parietal as well 
as temporal fields. Thus, our results are congruent with 
reports of an overall reduced nerve cell density [108], 
selective loss of pyramidal neurones containing a non-
phosphorylated neurofilament reactive to a monoclonal 
(SMI-32) antibody [25], reduced nerve cell density in 
layers V and VI [108, 109], and probable hypertrophy of 
a subset of pyramidal neurones [109]. One conspicuous 
feature in low-power microscopic inspection of serial 
frontal sections was a clearly demarcated layer IV in iso-
cortical fields. This phenomenon, which is rather diag-
nostic in our experience, has been interpreted differ-
ently. Vogt and Vogt [119] regarded the pronounced 
layer IV to be due to laminar accumulation of astroglia 
cells. In citing Kolpin (1912), Brodmann [18] suspected 
disturbed neocortical development (Vitium primae for-
mationis) in Huntington's disease. We think this phe-
nomenon is due to the degeneration of layer Va pyrami-
dal cells and a subsequent closer spacing of layer IV 
granule cells. A recent quantitative investigation failed 
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to demonstrate conspicuous astroglial proliferation in 
the prefrontal cortex of Huntington's disease patients 
[108]. Our results are in agreement with the neuro-
chemical investigations of Ellison et al. [35], who found 
reduced glutamate but unchanged GABA concentra-
tions in the frontal, parietal, and occipital lobes. 
Almost all smooth nonpyramidal cells (neurones 
with short axons and sparsely spiny dendrites) are 
GABA-ergic [29] and perhaps these spared cells render 
layer IV/V more distinct in Huntington's disease (Figs. 
4, 6). Reynolds and Pearson [97], on the other hand, 
reported decreased glutamate as well as GABA con-
centrations in the temporal lobe of Huntington's disease 
patients. Differences in the topography as well as differ-
ences in clinical staging could contribute to these dis-
crepancies. 
Pathoarchitectonics and functional considerations 
The psychiatric and neurological pictures of Hunting-
ton's disease have mainly been explained by neuronal 
depletion in the striatum and affliction of cortico-basal 
ganglia-cortical circuits [22, 26, 39, 48, 81, 82, 112, 128]. 
Decreased laminar as well as area-specific neurone 
number represent additional factors to be considered in 
the pathophysiology of Huntington's disease. Selective 
loss of layer IH, V, and VI pyramidal neurones may be 
due to retrograde degeneration after death of small 
spiny striatal neurones that are the major targets of 
cortical projection cells [6, 37, 43, 65, 66, 84, 88]. These 
retrograde phenomena could explain nerve cell loss in 
frontal, parietal, occipital, and temporal association 
cortices. At variance with previous conclusions that 
favoured a restricted topographical pattern of cortico-
striatal projections [68], recent investigations demonst-
rated a widespread longitudinal termination of frontal, 
parietal, occipital, and temporal lobe pyramidal neu-
rone efferents in the caudate nucleus [36, 42, 43, 65, 72, 
78,94, 103, 111, 118, 127]. On the other hand, the pri-
mary visual area of monkeys has few, if any, direct con-
nections with the caudate nucleus and ventral putamen 
[103]. Furthermore, the projection of primary sensory 
areas to the caudate nucleus are faint in monkeys [73]. 
It is generally agreed that the caudate nucleus is primar-
ily afflicted in Huntington's disease. These observations 
favour additional mechanisms of cortical neuronal 
death besides retrograde degeneration. In addition, 
electrophysiological observations in early stages of 
Huntington's disease suggest an early affliction of pri-
mary somatosensory fields [1, 34, 62, 87, 117]. Josiassen 
et al. [67] described visual as well as auditory deficits in 
asymptomatic offsprings of Huntington's disease pa-
tients. These stages exhibit slight or absent striatal 
degeneration in post-mortem [86] and NMR studies 
[44]. Therefore, we interpret the marked laminar nerve 
cell loss in areas 1-3, 17, and 41 as terminal stages of an 
early-onset cortical neuronal degeneration. 
Neuronal depletion has been reported in other neu-
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ropsychiatric diseases including Alzheimer's and Pick's 
disease. In the latter, marked striatal degeneration has 
frequently been described [77]. At variance with Hunt-
ington's disease, Pick's disease is characterized by pro-
gressive neuronal degeneration from layer 11 to III to V 
in the frontal and temporal lobes [24, 61, 64, 106], 
whereas Lange [75] pointed to a marked atrophy of 
parietal and occipital lobes in Huntington's disease. 
Layer III and layer V of temporal areas 21 and 22 are 
prone to synapse loss in Alzheimer's disease [105] and a 
subset of pyramidal cells in layers III and V appears to 
be afflicted by senile processes and preferentially lost in 
this disease and in HIV encephalopathy [7,14,23,27, 
52,59,60, 76, 125]. Taken together, these observations 
show laminar and areal similarities as well as differ-
ences of nerve cell degeneration in Huntington's, Pick's 
and Alzheimer's disease, and in virus-induced demen-
tia. 
Nevertheless, a coherent morphological explanation 
of clinical phenomena in these major neurodegenera-
tive diseases is presently not possible. Diffuse cortical 
nerve cell loss is insufficient to explain dementia. In a 
preliminary study [56] we found 4.4x 109 cortical neu-
rones with considerable astrogliosis in a non-demented 
72-year-old male. The cortex in this case contained only 
about 108 neurones more than the least affected cortex 
in a 54-year-old female patient with Huntington's dis-
ease (Table 4). Senile and amyloid plaques were absent 
in this 72-year-old male. Reinvestigation of the clinical 
records revealed that the patient had suffered from 
severe arteriosclerosis and had both thighs amputated. 
In Huntington's disease, besides the involvement of 
subcortical grisea, allocortical regions are invariably 
affected in the course of the illness. Interestingly, the 
laminar pathology of the entorhinal region in Hunting-
ton's disease differs markedly from Alzheimer's disease. 
The pre-alpha layer exhibits massive neurofibrillary 
tangles in Alzheimer's disease [8, 11, 47, 63, 93, 100], 
whereas the pre-beta and pri-layers are attenuated in 
Huntington's disease [12, 13,57]. The latter laminae are 
known to connect hippocampal with neocortical fields 
[126]. Neuropsychological tests have been claimed to 
distinguish memory deficits found in Huntington's dis-
ease from those seen in Alzheimer's disease [17, 21, 92, 
104]. 
In conclusion, sub-, neo- and allocortical regional 
and laminar neuronal degeneration in Huntington's dis-
ease represents a challenge towards a combined clinical-
morphological approach in unravelling the pathophys-
iology of this disease and the function of the human 
eNS in general. 
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